Serum Institute of India chief executive Adar Poonawalla said on Saturday that the company has begun the phase 2 and 3 clinical trial for Covovax and hopes to launch the vaccine by September. “Covovax trials finally begin in India; the vaccine is made through a partnership with Novavax and Serum Institute of India... Hope to launch by September 2021!" Poonawalla tweeted.
Serum Institute of India chief executive Adar Poonawalla said on Saturday that the company has begun the phase 2 and 3 clinical trial for Covovax and hopes to launch the vaccine by September. “Covovax trials finally begin in India; the vaccine is made through a partnership with Novavax and Serum Institute of India... Hope to launch by September 2021!" Poonawalla tweeted.